Navigation Links

Biology Technology

Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets

10/30/2014
(PRWEB) October 30, 2014 The report “Fragrance Ingredients Market by Type (Essential Oils and Aroma Chemicals), by Application (Cosmetics & Toiletries, and Soaps & Detergents) & by Geography - Global Trends & Forecasts to 2019”, has defined and segmented the Fragrance Ingredients Market with analyses and projection of the size and trends in terms of value. The market has bee... [Comments]

Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma

10/30/2014
LONDON , October 30, 2014 Investor-Edge has initiated coverage on the following equities: Organovo Holdings Inc. (NYSE MKT: ONVO), Medivation Inc. (NASDAQ: MDVN ), Pharmacyclics Inc. (NASDAQ: PCYC ), Synthetic Biologics Inc. (NYSE MKT: SYN), and Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD). Free research on these five companies can be accessed at: http://investor-edge.c... [Comments]

Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014

10/30/2014
FREMONT, Calif. , Oct. 30, 2014  Ardelyx, Inc. (NASDAQ: ARDX ), a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced that it will report third quarter 2014 financial results on Thursday, November 6, 2014. Following the announcement, the Ardelyx management team will host a live conference call and web... [Comments]

Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study

10/30/2014
London, UK (PRWEB) October 29, 2014 Global polyvinyl chloride (PVC) demand registered a significant decrease because of the world economic crisis during 2008-2009, especially in North America and Europe. However, the global PVC demand has recovered and currently is keeping to a growing trend. The largest chunk of the total PVC output volume is utilized in the construction segment. In 201... [Comments]

Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com

10/30/2014
Dallas, Texas (PRWEB) October 30, 2014 2014 Deep Research Report on Global and China Naltrexone HCL Industry” is a professional and in-depth research report on the China Naltrexone HCLmarket. The report provides basic Naltrexone HCL information, including its definition, classification, application, and industry chain structure as well as industry overview. This research covers the internat... [Comments]

Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase

10/30/2014
Chicago, Illinois (PRWEB) October 30, 2014 On October 26th at the Mid American Regenerative and Cellular Medicine Showcase in Chicago, leading applied stem cell research scientist Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna presented talks on New Techniques for Enhancing Stem Cell Therapy Effectiveness and Orthopedic Surgical Applications For Stem Cells. Dr. Riordan focuse... [Comments]

SoundConnect Launches Voice Enablement and Hybrid Audio Conferencing for Office 365

10/30/2014
BOSTON, MA (PRWEB) October 30, 2014 SoundConnect , an industry leading unified communication and collaboration provider, offers Office 365 end users the key to turning this already powerful software into a complete phone system by adding voice enablement and hybrid audio conferencing. Microsoft Office 365 (O365) includes Lync Online, a communication tool that includes presence, instant... [Comments]

Rancho BioSciences Manually Curated TCGA Data Sets Available

10/30/2014
San Diego, CA (PRWEB) October 30, 2014 Rancho BioSciences , the scientific data consulting company announced today that they have manually curated public data source TCGA for several of their Pharma and non profit customers. the data is now available for other oncology groups. Rancho BioSciences manually curates and unifies public and internal data sources for their Pharma, Government... [Comments]

Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells

10/30/2014
Boston, MA (PRWEB) October 30, 2014 James Sherley says he has been working towards ASCTC ’s new advance in adult tissue stem cell technology since his days as a principal investigator at the Fox Chase Cancer Center (FCCC) in Philadelphia in the late 1990’s. Sherley founded the ASCTC as a new Boston biotech start-up last year. The company holds all the intellectual property developed in S... [Comments]

Health Canada approves first near-patient DNA test for personalized medicine

10/30/2014
Ottawa, Ontario (PRWEB) October 30, 2014 Spartan Bioscience announced today that Health Canada has approved the Spartan RX CYP2C19 System . It detects CYP2C19 genetic mutations in less than 60 minutes from a non-invasive cheek swab. The Spartan RX CYP2C19 System is the first near-patient DNA test for personalized medicine that has been approved in Canada. Due to the system’s ease of use... [Comments]

Whitehouse Labs Announces Major Capital Investment in Stability and Storage Testing Capacity

10/30/2014
New York, NY (PRWEB) October 30, 2014 Whitehouse Laboratories has formally announced a major capital investment plan for its ICH Stability Testing and Package Test Capacity. Responding to growing demands from life science companies, this investment centers on a dramatic increase in environmental chamber storage space that will enable a much larger volume of stability, storage and aging samp... [Comments]

Medicine Technology

Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines

10/30/2014
CHARLOTTETOWN , Oct. 30, 2014 /CNW/ - Atlantic Canadians will save an estimated $560-million through an unprecedented three-year agreement reached between Canada's provinces and territories and the generic pharmaceutical industry, Jim Keon , President of the Canadian Generic Pharmaceutical Association (CGPA), said today. Mr. Keon made the comments while speaking at the Atlantic Summit... [Comments]

Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014

10/30/2014
FARMINGDALE, N.Y. , Oct. 30, 2014  Misonix, Inc. (NASDAQ: MSON ), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, announced today that it will report financial results for the first quarter fiscal year 2015 on Thursday,... [Comments]

Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship

10/30/2014
MAHWAH, N.J. , Oct. 30, 2014 Stryker Orthopaedics, the Official Joint Replacement Products of the PGA TOUR and Champions Tour, is rounding out its debut year of the relationship at the Charles Schwab Cup Championship in Scottsdale, AZ. This marks the eleventh tournament stop along both the PGA TOUR and Champions Tour that the brand has activated on-site with the "Stryker M... [Comments]

Grand Opening of NxStage Kidney Care Oak Brook IL Center

10/30/2014
LAWRENCE, Mass. , Oct. 30, 2014   NxStage® Kidney Care, Inc ., a subsidiary of NxStage® Medical, Inc. (Nasdaq: NXTM ), is proud to host the grand opening ceremony of its Oak Brook, Illinois center at 1600 W. 16 th Street on November 20, 2014 from 3pm – 7pm. The Oak Brook center is operated by highly trained medical staff who are committed to pro... [Comments]

WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax

10/30/2014
SHANGHAI , Oct. 30, 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States , today announced the establishment of a representative office in the Tel Aviv area of Israel. ... [Comments]

Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing

10/30/2014
WARSAW, Ind. , Oct. 30, 2014  Zimmer Holdings, Inc. (NYSE: ZMH and SIX: ZMH) today announced the future executive leadership team and organizational structure of the combined company following the closing of the Biomet transaction.  Zimmer also announced that the combined organization will leverage the strength of both companies' brands and will be named Zimmer Bio... [Comments]

Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference

10/30/2014
MARLBOROUGH, Mass. , Oct. 30, 2014 Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the 2014 Credit Suisse Annual Healthcare Conference on Tuesday, November 11, 2014 in Phoenix , AZ.  Dan Brennan , executive vice president and chief financial officer, will make a presentation about the company beginning at approximately 8:00 a.m. PT followed... [Comments]

Electronic Health Record Usability: CIOs Weigh In

10/30/2014
MOUNTAIN VIEW, Calif. , Oct. 30, 2014  Electronic health records uptake in the U.S. has accelerated dramatically as a result of government initiatives and the considerable resources – both capital and time - healthcare providers have invested over the past five years. Electronic health records have become the heart of health IT, and U.S. clinicians use them on a dail... [Comments]

ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA

10/30/2014
LOS ANGELES , Oct. 30, 2014   ViaDerma, Inc. (OTCQB: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, has recently released a revolutionary new wound care drug called TetraStem. TetraStem is a topical liquid tetracycline-based antibiotic that uses a patent-pending innovative transdermal delivery system that can convert oral medication... [Comments]

Report: Drugstore Chains Drive Retail Clinic Growth

10/30/2014
NEW YORK , Oct. 30, 2014  The number of retail health clinics in the United States is growing steadily, thanks to drug store chains, according to Kalorama Information.  In recent years, as a result of the economic downturn, retail clinic growth had been at a standstill, but 2013-14 was a year of opportunities, as the number of retail clinics reached nearly 1,600 a... [Comments]

CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems

10/30/2014
WOONSOCKET, R.I. , Oct. 30, 2014 CVS Health (NYSE: CVS ) announced today it has entered into new clinical affiliations with three leading regional health systems to enhance access to high-quality, affordable health care services for patients. The collaborating health systems include Baptist Health System in Alabama ; Community Health Systems (CHS) affiliated hospitals whi... [Comments]

(Date:10/26/2014)... (PRWEB) October 26, 2014 The ... Routers, ADC, Network Security Equipment, WAN Optimization Appliances]: ... and segments the data center networking market into ... of revenues. The report also identifies the factors ... opportunities impacting it along with the future roadmaps. ...
(Date:10/25/2014)... 25, 2014 The report “Adipic ... by Geography - Global Trends & Forecast to ... respect to market drivers, opportunities, and trends in ... and 27 figures spread through 217 slides and ... Trends & Forecast to 2019”., http://www.marketsandmarkets.com/Market-Reports/adipic-acid-269.html , ...
(Date:10/25/2014)... BioProcess International (BPI), a business-to-business ... BioProcess International Awards. The awards celebrate the outstanding ... technology applications that will allow the industry to ... patient base. , Winners and finalists were honored ... entertaining and exciting awards dinner and ceremony yesterday ...
(Date:10/25/2014)... Iowa (PRWEB) October 24, 2014 ... Perdue plans to more than double the acreage ... in geographies supplying its soybean crush facility in ... from this program will target several markets including ... alternatives with good performance. , For the 2015 ...
Breaking Biology Technology:Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 2Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 3Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 4Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 2Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 3Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 2BioProcess International Announces Winners of the 2014 BioProcess International Awards 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 5DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 2DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 3DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 4
... Regulus Therapeutics Inc ., a biopharmaceutical company leading the ... collaborators at NYU Langone Medical Center and Wake Forest ... pre-clinical research findings in the journal Nature ... 20, 2011). The new data show the first demonstration ...
... from the pivotal TEMSO Phase III study presented today at the joint ... Accepts New Drug Application for   Teriflunomide for relapsing forms ... SNY ) and its subsidiary Genzyme announced today new data ... O ral (TEMSO) Phase III trial showing that once-daily oral teriflunomide ...
... single-step process, engineers and scientists at the University ... to direct benign, filamentous viruses called M13 phages ... with a wide range of properties. By ... the viruses to self-assemble into hierarchically organized thin-film ...
Cached Biology Technology:Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 2Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 3Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 4Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 5Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 6Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism 7Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 2Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 3Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 4Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 5Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis 6Manufacturing goes viral 2Manufacturing goes viral 3Manufacturing goes viral 4
(Date:10/30/2014)... Oct. 30, 2014  Nektar Therapeutics (Nasdaq: ... third quarter ended September 30, 2014 on Thursday, November ... Howard Robin , president and chief executive officer, ... beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific ... a live audio-only Webcast of the conference call can ...
(Date:10/30/2014)... 30, 2014   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues, today ... results will be released on Thursday, November 6, 2014, ... and live webcast at 1:30 p.m. PST that afternoon. ...
(Date:10/30/2014)... , October 30, 2014 ... hilft beim Aufbau von Kuhmilchverträglichkeit     ... Lebensmittelallergien bei Säuglingen und Kleinkindern. Der bisher ... der Ernährung der Babys bzw. deren stillenden ... jedoch, dass sich bei einer beträchtlichen Anzahl ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2BioLife Solutions to Report Financial Results for Third Quarter 2014 and Provide Business Update on November 6, 2014 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 3
... 28, 2012 The Pharmacy Technician ... launch of the Employer Partnership Program , designed ... to encourage pharmacy technicians to participate in the PTCB ... Partner, employers receive a variety of complimentary benefits and ...
...  The Food and Drug Administration advisory panel voted on ... the FDA approve the prescription obesity drug Qnexa.  If ... than a decade that a prescription weight-loss medication receives ... Health Congress (CMHC) expert faculty to weigh in on ...
Cached Medicine Technology:PTCB Announces New Employer Partnership Program 2Cardiometabolic Health Congress Expert Faculty Weigh in on FDA Advisory Panel Recommendation for Novel Weight-Loss Medication 2Cardiometabolic Health Congress Expert Faculty Weigh in on FDA Advisory Panel Recommendation for Novel Weight-Loss Medication 3